File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.jcct.2025.07.009
- Scopus: eid_2-s2.0-105014023527
- PMID: 40769832
- Find via

Supplementary
- Citations:
- Appears in Collections:
Article: Intravenous metoprolol and diltiazem drug combination therapy for heart rate control in coronary CT angiograms
| Title | Intravenous metoprolol and diltiazem drug combination therapy for heart rate control in coronary CT angiograms |
|---|---|
| Authors | |
| Keywords | Adverse events Combination drug therapy Coronary CT angiogram Diltiazem Heart rate control Metoprolol |
| Issue Date | 6-Aug-2025 |
| Publisher | Elsevier |
| Citation | Journal of Cardiovascular Computed Tomography, 2025 How to Cite? |
| Abstract | Heart rate control by metoprolol yields better image quality for CT coronary angiograms (CTCA). When metoprolol fails to satisfactorily reduce heart rate, drug combinations can be used. The safety profile of combining metoprolol and diltiazem for CTCA is unknown but known risks include atrioventricular nodal block, bradycardia, hypotension and heart failure. |
| Persistent Identifier | http://hdl.handle.net/10722/366851 |
| ISSN | 2023 Impact Factor: 5.5 2023 SCImago Journal Rankings: 1.418 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yu, Sze Jin Adrian | - |
| dc.contributor.author | Cheung, Chi Wai Stephen | - |
| dc.contributor.author | Ng, Ming Yen | - |
| dc.date.accessioned | 2025-11-26T02:50:32Z | - |
| dc.date.available | 2025-11-26T02:50:32Z | - |
| dc.date.issued | 2025-08-06 | - |
| dc.identifier.citation | Journal of Cardiovascular Computed Tomography, 2025 | - |
| dc.identifier.issn | 1934-5925 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/366851 | - |
| dc.description.abstract | <p>Heart rate control by metoprolol yields better image quality for CT coronary angiograms (CTCA). When metoprolol fails to satisfactorily reduce heart rate, drug combinations can be used. The safety profile of combining metoprolol and diltiazem for CTCA is unknown but known risks include atrioventricular nodal block, bradycardia, hypotension and heart failure.<br></p> | - |
| dc.language | eng | - |
| dc.publisher | Elsevier | - |
| dc.relation.ispartof | Journal of Cardiovascular Computed Tomography | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | Adverse events | - |
| dc.subject | Combination drug therapy | - |
| dc.subject | Coronary CT angiogram | - |
| dc.subject | Diltiazem | - |
| dc.subject | Heart rate control | - |
| dc.subject | Metoprolol | - |
| dc.title | Intravenous metoprolol and diltiazem drug combination therapy for heart rate control in coronary CT angiograms | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1016/j.jcct.2025.07.009 | - |
| dc.identifier.pmid | 40769832 | - |
| dc.identifier.scopus | eid_2-s2.0-105014023527 | - |
| dc.identifier.issnl | 1876-861X | - |
